OptiBiotix Health inks Japan distribution agreement with EIWA Trading

Writer, Stock Market Wire
Monday, February 11, 2019 - 07:34

OptiBiotix Health said subsidiary ProBiotix Health had appointed EIWA Trading as the exclusive distributor of its cholesterol and blood pressure-reducing probiotic product in Japan.

The agreement granted EIWA the exclusive rights to import, market and distribute the s-called LPLDL product in Japan for a period of three years.

Market exclusivity was linked to increasing minimum annual volumes in order to maximise the financial return for both parties, which OptiBiotix said provided some surety of income.

'This deal provides OptiBiotix market access in Japan, the main national market for probiotics within the largest region for probiotics in the world,' chief executive Stephen O'Hara said.

'We have chosen EIWA as they are a well-known and respected provider of probiotics to the Japanese food, dairy and supplement industries, creating the potential to extend the use of LPLDL beyond supplements in a major international market.'

Related content

OptiBiotix Health inks license agreement with Tenshindo in Japan

OptiBiotix Health said subsidiary ProBiotix Health had signed a non-exclusive license agreement with Tenshindo for the use of Lactobacillus plantarum in cardiovascular food supplements in...

Wed, 03/07/2019 - 07:54

OptiBiotix Health inks licencing agreement with Kappa Bioscience

OptiBiotix Health said subsidiary ProBiotix Health had signed a license agreement with Kappa Bioscience.

The agreement covered the use of OptiBiotix Health's blood pressure-reducing probiotic...

Mon, 01/07/2019 - 08:51

OptiBiotix Health inks North America supply agreement with Agropur

OptiBiotix Health said it had entered into a manufacturing and distribution agreement with Agropur MSI for the US, Canada and Mexico.

The agreement granted Agropur...

Mon, 24/06/2019 - 07:13

OptiBiotix Health inks sales pact for Vietnam with Biovagen Healthcare

OptiBiotix Health said subsidiary ProBiotix Health had signed a license agreement with Biovagen Healthcare for the commercialisation of its cholesterol management products in Vietnam.


Mon, 10/06/2019 - 07:52

OptiBiotix Health appoints Stephen Prescott as CEO of ProBiotix unit

OptiBiotix Health said it had appointed Stephen Prescott as chief executive of its ProBiotix Health subsidiary.

ProBiotix was created to develop science-based healthy bacteria called...

Tue, 28/05/2019 - 07:39